La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Penumbra Gestione

Gestione criteri di controllo 4/4

Penumbra's Il CEO è Adam Elsesser, nominato in Jun2004, e ha un mandato di 20.17 anni. la retribuzione annua totale è $ 601.62K, composta da 99.7% di stipendio e 0.3% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 2.4% delle azioni della società, per un valore di $ 178.54M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 4.3 anni e 8.5 anni.

Informazioni chiave

Adam Elsesser

Amministratore delegato

US$601.6k

Compenso totale

Percentuale dello stipendio del CEO	99.7%
Mandato del CEO	20.2yrs
Proprietà del CEO	2.4%
Durata media del management	4.3yrs
Durata media del Consiglio di amministrazione	8.5yrs

Aggiornamenti recenti sulla gestione

Recent updates

Penumbra Grinding Through A Painful Growth Expectations Reset

Aug 20

What You Can Learn From Penumbra, Inc.'s (NYSE:PEN) P/S

Aug 01

Penumbra, Inc. (NYSE:PEN) Shares Could Be 23% Above Their Intrinsic Value Estimate

Jul 11

Penumbra: Future Upside Drivers In Fundamental, Sentimental And Valuation Factors

Jun 22

Getting In Cheap On Penumbra, Inc. (NYSE:PEN) Might Be Difficult

Jun 02

We're Not Worried About Penumbra's (NYSE:PEN) Cash Burn

Apr 01

Penumbra Non-GAAP EPS of $0.16 beats by $0.01, revenue of $221.22M beats by $4.19M

Feb 23

Penumbra Riding Higher On Upcoming Launches And Rerating

Jan 12

Penumbra: Today's Best Medical Equipment Nearby Cap-Gain Buy

Nov 03

Penumbra cut to Neutral at Citi on macro concerns

Oct 05

Penumbra, Asahi team up to bring blood clot removing device Indigo to Japan

Sep 22

Penumbra stock rises ~11% after announcing European launch of catheters for stroke care

Sep 07

Sector Rerating Has Cast A Shadow Over Penumbra

Aug 18

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Adam Elsesser rispetto agli utili di Penumbra?
Data	Compenso totale	Stipendio	Guadagni aziendali
Jun 30 2024	n/a	n/a	US$14m
Mar 31 2024	n/a	n/a	US$93m
Dec 31 2023	US$602k	US$600k	US$91m
Sep 30 2023	n/a	n/a	US$41m
Jun 30 2023	n/a	n/a	US$29m
Mar 31 2023	n/a	n/a	US$6m
Dec 31 2022	US$602k	US$600k	-US$2m
Sep 30 2022	n/a	n/a	-US$31m
Jun 30 2022	n/a	n/a	-US$19m
Mar 31 2022	n/a	n/a	-US$6m
Dec 31 2021	US$498k	US$496k	US$5m
Sep 30 2021	n/a	n/a	US$34m
Jun 30 2021	n/a	n/a	US$16m
Mar 31 2021	n/a	n/a	-US$5m
Dec 31 2020	US$219k	US$217k	-US$16m
Sep 30 2020	n/a	n/a	-US$10m
Jun 30 2020	n/a	n/a	US$11m
Mar 31 2020	n/a	n/a	US$39m
Dec 31 2019	US$727k	US$725k	US$48m
Sep 30 2019	n/a	n/a	US$45m
Jun 30 2019	n/a	n/a	US$15m
Mar 31 2019	n/a	n/a	US$12m
Dec 31 2018	US$727k	US$725k	US$7m
Sep 30 2018	n/a	n/a	US$9m
Jun 30 2018	n/a	n/a	US$28m
Mar 31 2018	n/a	n/a	US$13m
Dec 31 2017	US$727k	US$725k	US$5m

Compensazione vs Mercato: La retribuzione totale di Adam ($USD 601.62K ) è inferiore alla media delle aziende di dimensioni simili nel mercato US ($USD 8.39M ).

Compensazione vs guadagni: La retribuzione di Adam è stata coerente con le performance aziendali dell'ultimo anno.

AMMINISTRATORE DELEGATO

Adam Elsesser (62 yo)

20.2yrs

Mandato

US$601,620

Compensazione

Mr. Adam Elsesser serves as President at Penumbra, Inc. since May 2020. He Co-Founded Penumbra, Inc. in 2004 and has been its Chief Executive Officer and Director since June 2004. Mr. Elsesser has been the...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Adam Elsesser	Co-Founder	20.2yrs	US$601.62k	2.4% $ 188.4m
Arani Bose	Co-Founder & Director	20.2yrs	US$233.99k	0.87% $ 68.2m
Maggie Yuen	Chief Financial Officer	4.7yrs	US$666.04k	0.016% $ 1.3m
Lambert Shiu	Chief Accounting Officer	4.7yrs	US$539.94k	0.041% $ 3.2m
Johanna Roberts	Executive VP	5.9yrs	US$661.89k	0.13% $ 10.5m
Ben Sorci	Executive Vice President of Operations	3.6yrs	Nessun dato	Nessun dato
Pankaj Tiwari	Executive VP & Chief Information Officer	2.6yrs	Nessun dato	Nessun dato
Jee Hamlyn-Harris	Investor Relations Officer	no data	Nessun dato	Nessun dato
Ben Tompkins	Executive Vice President of Development & Compliance	less than a year	Nessun dato	Nessun dato
Gita Barry	President of Immersive Healthcare	3.6yrs	Nessun dato	Nessun dato
Shruthi Narayan	Executive VP & GM of Interventional	1.6yrs	Nessun dato	Nessun dato
Jason Mills	Executive Vice President of Strategy	4.3yrs	Nessun dato	Nessun dato

4.3yrs

Durata media

52yo

Età media

Gestione esperta: Il team dirigenziale di PEN è considerato esperto (durata media dell'incarico 4.3 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Adam Elsesser	Co-Founder	20.2yrs	US$601.62k	2.4% $ 188.4m
Arani Bose	Co-Founder & Director	20.2yrs	US$233.99k	0.87% $ 68.2m
Harpreet Grewal	Independent Director	9.3yrs	US$241.49k	0.024% $ 1.8m
Thomas Wilder	Independent Director	7.6yrs	US$258.99k	0.012% $ 955.2k
Don Kassing	Presiding Independent Director	16.5yrs	US$246.49k	0.024% $ 1.9m
Surbhi Sarna	Independent Director	5.1yrs	US$248.99k	0.0063% $ 497.6k
Bridget O'Rourke	Independent Director	7.3yrs	US$263.99k	0.011% $ 885.4k
Janet Leeds	Independent Director	5.6yrs	US$251.49k	0.012% $ 971.7k

8.5yrs

Durata media

60.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di PEN sono considerati esperti (durata media dell'incarico 8.5 anni).

Penumbra Gestione

Gestione criteri di controllo 4/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Co-Founder notifies of intention to sell stock

Co-Founder notifies of intention to sell stock

Penumbra, Inc., Annual General Meeting, Jun 05, 2024

Executive VP notifies of intention to sell stock

Executive VP notifies of intention to sell stock

Co-Founder exercised options and sold US$2.0m worth of stock

Recent updates

Co-Founder notifies of intention to sell stock

Penumbra Grinding Through A Painful Growth Expectations Reset

Penumbra, Inc. (NYSE:PEN) announces an Equity Buyback for $200 million worth of its shares.

Consensus EPS estimates fall by 72%

What You Can Learn From Penumbra, Inc.'s (NYSE:PEN) P/S

Second quarter 2024 earnings: EPS misses analyst expectations

Penumbra, Inc. (NYSE:PEN) Shares Could Be 23% Above Their Intrinsic Value Estimate

Penumbra, Inc. to Report Q2, 2024 Results on Jul 30, 2024

Now 21% undervalued after recent price drop

Returns At Penumbra (NYSE:PEN) Appear To Be Weighed Down

Penumbra: Appeal Improves As Operating Leverage Continues

Co-Founder notifies of intention to sell stock

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Penumbra, Inc. Reiterates Earnings Guidance for the Year 2024

Penumbra, Inc., Annual General Meeting, Jun 05, 2024

Penumbra, Inc. Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots

Penumbra, Inc.'s (NYSE:PEN) Earnings Haven't Escaped The Attention Of Investors

Penumbra, Inc. to Report Q1, 2024 Results on May 07, 2024

Estimating The Intrinsic Value Of Penumbra, Inc. (NYSE:PEN)

Executive VP notifies of intention to sell stock

Full year 2023 earnings: EPS exceeds analyst expectations

Penumbra, Inc. Provides Earnings Guidance for the Full Year 2024

Now 21% overvalued after recent price rise

Now 23% overvalued after recent price rise

Penumbra, Inc. to Report Q4, 2023 Results on Feb 22, 2024

Some Investors May Be Worried About Penumbra's (NYSE:PEN) Returns On Capital

Executive VP notifies of intention to sell stock

Penumbra, Inc. Announces First Patient in STORM-PE RCT Enrolled Evaluating Penumbra's Latest Computer Assisted Vacuum Thrombectomy - Lightning Flash for Treatment of Acute Pulmonary Embolism

A Look At The Fair Value Of Penumbra, Inc. (NYSE:PEN)

Now 21% undervalued after recent price drop

Penumbra, Inc. Provides Earnings Guidance for the Full Year 2023

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Penumbra, Inc. Announces Latest STRIKE-PE Data Evaluating Penumbra's Indigo Aspiration System with Lightning

Price target decreased by 8.5% to US$301

Penumbra: Appeal Improves, Just Not Appealing Yet

Co-Founder exercised options and sold US$2.0m worth of stock

Now 20% undervalued after recent price drop

Penumbra, Inc. to Report Q3, 2023 Results on Nov 02, 2023

Returns On Capital Signal Tricky Times Ahead For Penumbra (NYSE:PEN)

Co-Founder exercised options and sold US$2.8m worth of stock

Executive VP notifies of intention to sell stock

Penumbra: Consolidation Does Nothing To Change Long-Term Thesis, Reiterate Buy

A Look At The Intrinsic Value Of Penumbra, Inc. (NYSE:PEN)

Co-Founder notifies of intention to sell stock

Consensus EPS estimates increase by 16%

New minor risk - Shareholder dilution

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Co-Founder exercised options and sold US$3.0m worth of stock

Penumbra, Inc. to Report Q2, 2023 Results on Aug 01, 2023

Penumbra (NYSE:PEN) Has Some Way To Go To Become A Multi-Bagger

Penumbra: Future Upside Drivers In Fundamental, Sentimental And Valuation Factors

Co-Founder exercised options and sold US$3.1m worth of stock

Executive VP notifies of intention to sell stock

Penumbra Expands Computer-Aided Thrombectomy Offerings with Lightning Bolt 7 Technology Designed to Rapidly Remove Blood Clots with Modulated Aspiration

Getting In Cheap On Penumbra, Inc. (NYSE:PEN) Might Be Difficult

Penumbra, Inc. Updates Revenue Guidance for the Full Year 2023

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Executive VP exercised options and sold US$154k worth of stock

We're Not Worried About Penumbra's (NYSE:PEN) Cash Burn

Independent Director notifies of intention to sell stock

Executive VP notifies of intention to sell stock

Price target increased by 11% to US$291

Price target increased by 7.2% to US$272

Penumbra Non-GAAP EPS of $0.16 beats by $0.01, revenue of $221.22M beats by $4.19M

Presiding Independent Director notifies of intention to sell stock

Co-Founder & Director notifies of intention to sell stock

Penumbra, Inc. to Report Q4, 2022 Results on Feb 23, 2023

Penumbra Riding Higher On Upcoming Launches And Rerating

Penumbra, Inc. Launches Latest Innovation in Mechanical Thrombectomy, Lightning Flash